Zobrazeno 1 - 10
of 102
pro vyhledávání: '"PRDX5"'
Publikováno v:
Molecular Medicine, Vol 29, Iss 1, Pp 1-19 (2023)
Abstract Background Maresin1 (MaR1) is a potent lipid mediator that exhibits significant anti-inflammatory activity in the context of several inflammatory diseases. A previous study reported that MaR1 could suppress MSU crystal-induced peritonitis in
Externí odkaz:
https://doaj.org/article/9b28b92c57a94cb7abac0d126c87b4ee
Publikováno v:
Cells, Vol 12, Iss 13, p 1713 (2023)
(1) Background: Tuberous sclerosis complex (TSC) mutations directly affect mTORC activity and, as a result, protein synthesis. In several cancer types, TSC mutation is part of the driver mutation panel. TSC mutations have been associated with mitocho
Externí odkaz:
https://doaj.org/article/8f70ddf7338b4eb8923dd028c40b7809
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mégane A. Poncin, Pierre Van Meerbeeck, Joshua D. Simpson, André Clippe, François Tyckaert, Fabrice Bouillenne, Hervé Degand, André Matagne, Pierre Morsomme, Bernard Knoops, David Alsteens
Publikováno v:
Antioxidants, Vol 10, Iss 12, p 1902 (2021)
Human peroxiredoxin-5 (PRDX5) is a unique redox-sensitive protein that plays a dual role in brain ischemia-reperfusion injury. While intracellular PRDX5 has been reported to act as a neuroprotective antioxidative enzyme by scavenging peroxides, once
Externí odkaz:
https://doaj.org/article/486e8150528c4f38ad31f2c78e3150f9
Publikováno v:
Cells; Volume 12; Issue 13; Pages: 1713
(1) Background: Tuberous sclerosis complex (TSC) mutations directly affect mTORC activity and, as a result, protein synthesis. In several cancer types, TSC mutation is part of the driver mutation panel. TSC mutations have been associated with mitocho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::b6eec0c5c4d795e4a9dbae38cabd2c92
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
International Journal of Molecular Medicine
Deoxyribonucleic acid (DNA) epigenetic modification has been linked to specific sequences of CpG islands and plays roles in the progression of lung cancer. In this study, it was found that peroxiredoxin‑5 (PRDX5) was highly expressed in non‑small
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5f1ea77b8db3781f7ee3b2d1ce9c0de
http://europepmc.org/articles/PMC7797423
http://europepmc.org/articles/PMC7797423
Publikováno v:
Aging (Albany NY)
Non-small-cell lung cancer (NSCLC) is one of the most common malignant tumors in the world. Reactive oxidative species (ROS) and nuclear factor-related factor 2 (Nrf2) -antioxidant response element (ARE) signal pathway are known to play important rol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95743c92de1531153c44bf0068d4f68d
https://doi.org/10.18632/aging.102605
https://doi.org/10.18632/aging.102605
Publikováno v:
ChemMedChem. 16(22)
The peroxiredoxin 5 (PRDX5) is a member of peroxiredoxins with antitumor activity. However, as a recombinant protein, PRDX5 is restricted in clinic due to high cost and keeping high dose in medication. The alternative way is to explore the antitumor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e28b7d9021a008face16587934af3a7e
https://pubmed.ncbi.nlm.nih.gov/34313010
https://pubmed.ncbi.nlm.nih.gov/34313010